Status:
COMPLETED
Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAs
Lead Sponsor:
Slovak Academy of Sciences
Collaborating Sponsors:
University Hospital Bratislava
Conditions:
Mild Cognitive Impairment
Alzheimer Disease
Eligibility:
All Genders
60-85 years
Phase:
NA
Brief Summary
The purpose of this study is to determine specific changes in muscle secretory profile (myokines, miRNA) in association with neurodegenerative disease progression and metabolic dysfunction. Next the i...
Detailed Description
Standard Operating Procedures for patient recruitment, data collection, data management, data analysis routinely used in University Hospital Bratislava and in Institute of Experimental Endocrinology S...
Eligibility Criteria
Inclusion
- Signed informed consent.
- Diagnosed with Parkinson disease
- Diagnosed with mild cognitive impairment (MCI) or Alzheimer disease (AD)
Exclusion
- Serious systemic cardiovascular, hepatic, renal disease, cancer.
- Lack of compliance.
Key Trial Info
Start Date :
September 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02253732
Start Date
September 1 2015
End Date
March 1 2018
Last Update
April 17 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy Hospital in Bratislava
Bratislava, Slovakia, 81369
2
Inst. Exp. Endocrinology Slovak Acad Sci
Bratislava, Slovakia, 83306